What it means
Section 503A of federal law covers traditional compounding: a pharmacist or physician preparing a drug for a specific patient's prescription. State boards of pharmacy are the main regulators. These products are exempt from FDA approval, from federal good manufacturing rules and from full labeling.
Compounding has legitimate uses, such as removing an allergy-causing dye or making a liquid for someone who cannot swallow pills. Federal rules limit compounding of drugs that are essentially copies of approved products, except in situations such as an official shortage.
A 503A pharmacy can only use certain bulk ingredients, such as those in an approved drug or on an FDA-reviewed list. Products from these pharmacies are not checked by the FDA for safety, effectiveness or quality before use.
Larger-scale compounding falls under 503B outsourcing facilities, which follow stricter rules.
Why it matters
Most compounded GLP-1 products reach patients through 503A pharmacies, so knowing their limits helps you judge what you are getting.